Osgenic

Osgenic, founded in 2017, is a physician-led technology company based in Finland, primarily focused on reducing preventable surgical complications through innovative solutions in the field of orthopaedics, traumatology, and related disciplines. Operating under the slogan "High-quality resources for faster understanding of what matters in orthopaedics, traumatology and related disciplines," the company emphasizes the merger of medical science with cutting-edge technology.

The company's core strength lies in its deep integration with the medical community, being co-owned by over 500 medical doctors. This extensive network ensures that Osgenic is not only driven by scientific rigor but also tailored to the clinical needs of practitioners. Continuous feedback from these medical professionals informs the company's product development, resulting in solutions that seamlessly fit into actual clinical environments.

Their commitment to enhancing surgical safety attracted a $1.02M Series D investment led by Icebreaker.vc on 01 March 2019. For investors, Osgenic represents an opportunity to support a mission-centric company with close ties to its core user base, poised to impact surgical outcomes positively.